1. Home
  2. CTSO vs ELPW Comparison

CTSO vs ELPW Comparison

Compare CTSO & ELPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • ELPW
  • Stock Information
  • Founded
  • CTSO 1997
  • ELPW 2014
  • Country
  • CTSO United States
  • ELPW China
  • Employees
  • CTSO N/A
  • ELPW N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • ELPW
  • Sector
  • CTSO Health Care
  • ELPW
  • Exchange
  • CTSO Nasdaq
  • ELPW NYSE
  • Market Cap
  • CTSO 51.6M
  • ELPW 54.1M
  • IPO Year
  • CTSO N/A
  • ELPW N/A
  • Fundamental
  • Price
  • CTSO $1.15
  • ELPW $0.90
  • Analyst Decision
  • CTSO Strong Buy
  • ELPW
  • Analyst Count
  • CTSO 3
  • ELPW 0
  • Target Price
  • CTSO $4.67
  • ELPW N/A
  • AVG Volume (30 Days)
  • CTSO 147.4K
  • ELPW 99.7K
  • Earning Date
  • CTSO 03-06-2025
  • ELPW 03-04-2025
  • Dividend Yield
  • CTSO N/A
  • ELPW N/A
  • EPS Growth
  • CTSO N/A
  • ELPW N/A
  • EPS
  • CTSO N/A
  • ELPW N/A
  • Revenue
  • CTSO $37,739,531.00
  • ELPW N/A
  • Revenue This Year
  • CTSO $9.20
  • ELPW N/A
  • Revenue Next Year
  • CTSO $11.64
  • ELPW N/A
  • P/E Ratio
  • CTSO N/A
  • ELPW N/A
  • Revenue Growth
  • CTSO 1.80
  • ELPW N/A
  • 52 Week Low
  • CTSO $0.70
  • ELPW $0.90
  • 52 Week High
  • CTSO $1.61
  • ELPW $7.20
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 55.74
  • ELPW N/A
  • Support Level
  • CTSO $1.06
  • ELPW N/A
  • Resistance Level
  • CTSO $1.61
  • ELPW N/A
  • Average True Range (ATR)
  • CTSO 0.13
  • ELPW 0.00
  • MACD
  • CTSO 0.01
  • ELPW 0.00
  • Stochastic Oscillator
  • CTSO 29.34
  • ELPW 0.00

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About ELPW ELONG POWER HOLDING LIMITED

Elong Power Holding Ltd is engaged in research and development, manufacturing, sales, and service of high-power lithium-ion batteries for electric vehicles and construction machinery, as well as large-capacity, long-cycle lithium-ion batteries for energy storage systems. The company's lower-cost, high-power, and fast-charging batteries are designed specifically for commercial vehicles and specialty vehicles that require large-capacity energy storage systems. It operates in one operating segment and includes the manufacture, commercialization, and distribution of a variety of battery cells and battery packs for use in a wide array of applications.

Share on Social Networks: